Sponsored by the American Society of Plastic Surgeons® (ASPS®)
Plastic and Reconstructive Surgery® Editors:
Editor-in-Chief: Rod J. Rohrich, MD
Co-Editor: James M. Stuzin, MD
Section Editor: Donald H. Lalonde, MD
The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The ASPS designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Patient Safety Credit: 0.5
MOC-PS® Tracer Procedure: Dupuytren's disease
Media: Journal Article
Release Date: 12/1/2010
Expiration Date: 12/1/2013
Estimated time to complete this course: 1.0 hour
Minimum Post-test Score to Claim Credit: 80%
This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.
Surgical management, predominately limited fasciectomy, remains the mainstay treatment for Dupuytren’s contractures. No single procedure has proven completely effective, and recurrence rates remain high. This has lead some to recommend less invasive procedures for early stage disease. The purpose of this article is to provide a summary of the best available evidence on the treatment of Dupuytren's contracture that, when combined with individual clinical expertise, can assist the surgeon in the continuing evolution toward optimal outcomes.
Upon completion of the online course, the participant should be able to:
1. Summarize the best available evidence on the treatment of Dupuytren's contracture.
2. Evaluate their own clinical expertise in light of the best available evidence on Dupuytren's contracture.
3. Apply the best evidence to obtain optimal treatment outcomes for patients with Dupuytren's contracture.
Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwest. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. None of the authors have relevant financial relationships or affiliations to disclose. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.